Mark For: AMRAD® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 76434045 |
Registration Number | 2852572 |
Mark Literal Elements | AMRAD |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | POST REGISTRATION 2005-02-08 |
Basis | 44(e) |
Class Status | SECTION 8 - CANCEL |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | Yes |
44E Current | Yes |
66A Current | No |
Current Basis | No |
No Basis | No |
Cancellation Code | 2 |
Domestic Representative | BIRCH, STEWART, KOLASCH & BIRCH, LLP |
Attorney Name | TODD A. HARDY |
Attorney Docket Number | 0446-0138T |
Law Office Assigned | L50 |
Employee Name | JOHNSON, AISHA CLARKE |
2002-07-23 | Application Filed |
2004-03-23 | Published |
2004-03-23 | Published for Opposition |
2004-06-15 | Trademark Registered |
2005-02-08 | Location: POST REGISTRATION |
2011-01-21 | Cancelled |
2011-01-21 | Status: Dead/Cancelled |
2011-01-21 | Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this |
2018-07-08 | Transaction Date |
Party: | AMRAD Corporation Limited |
Address | 576 Swan Street Richmad, Victoria, 3121 AUSTRALIA |
Legal Entity Type | Corporation |
Legal Entity State | AUSTRALIA |
Application | 2002-07-23 | |
Drawing | 2002-07-23 | |
Duplicate Application | 2002-07-23 | |
Duplicate Drawing | 2002-07-23 | |
XSearch Search Summary | 2002-10-24 | |
XSearch Search Summary | 2002-10-28 | |
Offc Action Outgoing | 2002-10-29 | |
Response to Office Action | 2003-04-09 | |
Paper Correspondence Incoming | 2003-04-29 | |
Unclassified-Other | 2003-05-16 | |
Suspension Letter | 2003-05-20 | |
Suspension Letter | 2003-05-21 | |
Foreign Certified Registration | 2003-09-29 | |
Paper Correspondence Incoming | IMAGE/TIFF | 2003-09-29 |
File Jacket | 2003-10-24 | |
Notation to File | 2003-12-09 | |
Notice of Publication | APPLICATION/XML | 2004-03-03 |
Registration Certificate | 2004-06-15 | |
Paper Correspondence Incoming | 2004-09-23 | |
PR-Updated Reg Certificates | 2004-12-21 |
(CANCELLED)
IC 001. US 001 005 006 010 026 046. G & S: chemical preparations for scientific and research use, namely, proteinaceous reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA; reagents for scientific or medical research use, namely, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro and for the expression, isolation and detection of recombination; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use in detecting auto immune disease, microbial disease, protein levels, genetic abnormalities, and pathogens(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Medical and clinical medical reagents for use in maintaining embryos in culture, increasing embryo implantation, and capture and isolation of DNA, molecular biological reagents for use in the detection of nucleic acid sequences in-vitro; pharmaceutical preparation for human and veterinary use in the treatment of blood disorders, viral disease and nervous system dysfunction, cancer, bone disease, liver disease, cardiac disorders, infertility, pregnancy disorders, and inflammation; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology(CANCELLED)
IC 042. US 100 101. G & S: Product research and development in the field of drug discovery; research and development for new products for others in the field of drug discovery; medical and scientific research, namely, * conducting clinical trials; biotechnology * consultation and research; pharmaceutical drug development services(CANCELLED)
IC 044. US 100 101. G & S: Medical testing; pharmaceutical advice
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
B00001 | In the statement, Column 2, line 12, after NAMELY, CONDUCTING CLINICAL TRIALS; BIOTECHNOLOGY should be inserted. |
Description | Date | Proceeding Number |
---|---|---|
CANCELLED SEC. 8 (6-YR) | 2011-01-21 | |
CORRECTION UNDER SECTION 7 PROCESSED | 2004-11-12 | |
SEC 7 REQUEST FILED | 2004-09-23 | |
PAPER RECEIVED | 2004-09-23 | |
REGISTERED-PRINCIPAL REGISTER | 2004-06-15 | |
PUBLISHED FOR OPPOSITION | 2004-03-23 | |
NOTICE OF PUBLICATION | 2004-03-03 | |
Sec. 1(B) CLAIM DELETED | 2003-12-09 | 76611 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2003-12-09 | |
CASE FILE IN TICRS | 2003-10-27 | |
PAPER RECEIVED | 2003-09-29 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-09-29 | |
LETTER OF SUSPENSION MAILED | 2003-05-21 | |
PAPER RECEIVED | 2003-04-29 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-04-29 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-04-09 | |
ASSIGNED TO EXAMINER | 2003-01-03 | 76611 |
NON-FINAL ACTION MAILED | 2002-10-29 | |
ASSIGNED TO EXAMINER | 2002-10-22 | 76934 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.